TY - JOUR AU - Liersch, R. AU - Muller-Tidow, C. AU - Berdel, W. E. AU - Krug, U. PY - 2014 DA - 2014// TI - Prognostic factors for acute myeloid leukaemia in adults—biological significance and clinical use JO - Br J Haematol VL - 165 UR - https://doi.org/10.1111/bjh.12750 DO - 10.1111/bjh.12750 ID - Liersch2014 ER - TY - JOUR AU - Kern, W. AU - Haferlach, T. AU - Schoch, C. AU - Loffler, H. AU - Gassmann, W. AU - Heinecke, A. PY - 2003 DA - 2003// TI - Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 trial JO - Blood VL - 101 UR - https://doi.org/10.1182/blood-2002-02-0532 DO - 10.1182/blood-2002-02-0532 ID - Kern2003 ER - TY - JOUR AU - Rowe, J. M. AU - Kim, H. T. AU - Cassileth, P. A. AU - Lazarus, H. M. AU - Litzow, M. R. AU - Wiernik, P. H. PY - 2010 DA - 2010// TI - Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology Group JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.25263 DO - 10.1002/cncr.25263 ID - Rowe2010 ER - TY - STD TI - National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines): acute myeloid leukemia (Version 2.2017). http://www.nccn.org/professionals/physiciangls/pdf/aml.pdf. Accessed 9 April 2017. UR - http://www.nccn.org/professionals/physiciangls/pdf/aml.pdf ID - ref4 ER - TY - JOUR AU - Hussein, K. AU - Jahagirdar, B. AU - Gupta, P. AU - Burns, L. AU - Larsen, K. AU - Weisdorf, D. PY - 2008 DA - 2008// TI - Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia JO - Am J Hematol VL - 83 UR - https://doi.org/10.1002/ajh.21133 DO - 10.1002/ajh.21133 ID - Hussein2008 ER - TY - JOUR AU - Yanada, M. AU - Borthakur, G. AU - Ravandi, F. AU - Bueso-Ramos, C. AU - Kantarjian, H. AU - Estey, E. PY - 2008 DA - 2008// TI - Kinetics of bone marrow blasts during induction and achievement of complete remission in acute myeloid leukemia JO - Haematologica VL - 93 UR - https://doi.org/10.3324/haematol.12825 DO - 10.3324/haematol.12825 ID - Yanada2008 ER - TY - JOUR AU - Mattison, R. J. AU - Luger, S. M. AU - Lazarus, H. M. PY - 2013 DA - 2013// TI - New strategies for the evaluation of the nadir bone marrow following induction in acute myeloid leukemia JO - Curr Opin Hematol VL - 20 UR - https://doi.org/10.1097/MOH.0b013e32835d8207 DO - 10.1097/MOH.0b013e32835d8207 ID - Mattison2013 ER - TY - JOUR AU - Morris, T. A. AU - DeCastro, C. M. AU - Diehl, L. F. AU - Gockerman, J. P. AU - Lagoo, A. S. AU - Li, Z. PY - 2013 DA - 2013// TI - Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia JO - Leuk Res VL - 37 UR - https://doi.org/10.1016/j.leukres.2012.09.016 DO - 10.1016/j.leukres.2012.09.016 ID - Morris2013 ER - TY - JOUR AU - Vanhelleputte, P. AU - Nijs, K. AU - Delforge, M. AU - Evers, G. AU - Vanderschueren, S. PY - 2003 DA - 2003// TI - Pain during bone marrow aspiration: prevalence and prevention JO - J Pain Symptom Manag VL - 26 UR - https://doi.org/10.1016/S0885-3924(03)00312-9 DO - 10.1016/S0885-3924(03)00312-9 ID - Vanhelleputte2003 ER - TY - JOUR AU - Bain, B. J. PY - 2005 DA - 2005// TI - Bone marrow biopsy morbidity: review of 2003 JO - J Clin Pathol VL - 58 UR - https://doi.org/10.1136/jcp.2004.022178 DO - 10.1136/jcp.2004.022178 ID - Bain2005 ER - TY - JOUR AU - Salskov, A. AU - Tammisetti, V. S. AU - Grierson, J. AU - Vesselle, H. PY - 2007 DA - 2007// TI - FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3'-deoxy-3'-[18F]fluorothymidine JO - Semin Nucl Med VL - 37 UR - https://doi.org/10.1053/j.semnuclmed.2007.08.001 DO - 10.1053/j.semnuclmed.2007.08.001 ID - Salskov2007 ER - TY - JOUR AU - Agool, A. AU - Schot, B. W. AU - Jager, P. L. AU - Vellenga, E. PY - 2006 DA - 2006// TI - 18F-FLT PET in hematologic disorders: a novel technique to analyze the bone marrow compartment JO - J Nucl Med VL - 47 ID - Agool2006 ER - TY - JOUR AU - Agool, A. AU - Slart, R. H. AU - Kluin, P. M. AU - Wolf, J. T. AU - Dierckx, R. A. AU - Vellenga, E. PY - 2011 DA - 2011// TI - F-18 FLT PET: a noninvasive diagnostic tool for visualization of the bone marrow compartment in patients with aplastic anemia: a pilot study JO - Clin Nucl Med VL - 36 UR - https://doi.org/10.1097/RLU.0b013e31820aa1a1 DO - 10.1097/RLU.0b013e31820aa1a1 ID - Agool2011 ER - TY - BOOK AU - Swerdllow, S. AU - Campo, E. AU - Harris, N. L. PY - 2008 DA - 2008// TI - WHO classification of tumours of haematopoietic and lymphoid tissues PB - IARC Press CY - France ID - Swerdllow2008 ER - TY - JOUR AU - Vanderhoek, M. AU - Juckett, M. B. AU - Perlman, S. B. AU - Nickles, R. J. AU - Jeraj, R. PY - 2011 DA - 2011// TI - Early assessment of treatment response in patients with AML using [(18)F]FLT PET imaging JO - Leuk Res VL - 35 UR - https://doi.org/10.1016/j.leukres.2010.06.010 DO - 10.1016/j.leukres.2010.06.010 ID - Vanderhoek2011 ER - TY - JOUR AU - Cheson, B. D. AU - Bennett, J. M. AU - Kopecky, K. J. AU - Buchner, T. AU - Willman, C. L. AU - Estey, E. H. PY - 2003 DA - 2003// TI - Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.04.036 DO - 10.1200/JCO.2003.04.036 ID - Cheson2003 ER - TY - JOUR AU - Shih, T. T. AU - Hou, H. A. AU - Liu, C. Y. AU - Chen, B. B. AU - Tang, J. L. AU - Chen, H. Y. PY - 2009 DA - 2009// TI - Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survival JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2008-08-173104 DO - 10.1182/blood-2008-08-173104 ID - Shih2009 ER - TY - JOUR AU - Hou, H. A. AU - Shih, T. T. AU - Liu, C. Y. AU - Chen, B. B. AU - Tang, J. L. AU - Yao, M. PY - 2010 DA - 2010// TI - Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia JO - Haematologica VL - 95 UR - https://doi.org/10.3324/haematol.2009.019364 DO - 10.3324/haematol.2009.019364 ID - Hou2010 ER - TY - JOUR AU - Chen, B. B. AU - Hsu, C. Y. AU - Yu, C. W. AU - Hou, H. A. AU - Liu, C. Y. AU - Wei, S. Y. PY - 2011 DA - 2011// TI - Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission JO - Radiology VL - 258 UR - https://doi.org/10.1148/radiol.10100995 DO - 10.1148/radiol.10100995 ID - Chen2011 ER - TY - STD TI - Valls L, Badve C, Avril S, Herrmann K, Faulhaber P, O'Donnell J, et al. FDG-PET imaging in hematological malignancies. Blood Rev. 2016;30:317–31. ID - ref20 ER - TY - JOUR AU - Trigonis, I. AU - Koh, P. K. AU - Taylor, B. AU - Tamal, M. AU - Ryder, D. AU - Earl, M. PY - 2014 DA - 2014// TI - Early reduction in tumour [18F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone JO - Eur J Nucl Med Mol Imaging VL - 41 UR - https://doi.org/10.1007/s00259-013-2632-3 DO - 10.1007/s00259-013-2632-3 ID - Trigonis2014 ER - TY - JOUR AU - Crippa, F. AU - Agresti, R. AU - Sandri, M. AU - Mariani, G. AU - Padovano, B. AU - Alessi, A. PY - 2015 DA - 2015// TI - (1)(8)F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot study JO - Eur J Nucl Med Mol Imaging VL - 42 UR - https://doi.org/10.1007/s00259-015-2995-8 DO - 10.1007/s00259-015-2995-8 ID - Crippa2015 ER - TY - JOUR AU - Minamimoto, R. AU - Fayad, L. AU - Advani, R. AU - Vose, J. AU - Macapinlac, H. AU - Meza, J. PY - 2016 DA - 2016// TI - Diffuse large B-cell lymphoma: prospective multicenter comparison of early interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST criteria for early therapeutic monitoring JO - Radiology VL - 280 UR - https://doi.org/10.1148/radiol.2015150689 DO - 10.1148/radiol.2015150689 ID - Minamimoto2016 ER - TY - JOUR AU - Schoder, H. AU - Zelenetz, A. D. AU - Hamlin, P. AU - Gavane, S. AU - Horwitz, S. AU - Matasar, M. PY - 2016 DA - 2016// TI - Prospective study of 3'-Deoxy-3'-18F-fluorothymidine PET for early interim response assessment in advanced-stage B-cell lymphoma JO - J Nucl Med VL - 57 UR - https://doi.org/10.2967/jnumed.115.166769 DO - 10.2967/jnumed.115.166769 ID - Schoder2016 ER - TY - JOUR AU - Barthel, H. AU - Perumal, M. AU - Latigo, J. AU - He, Q. AU - Brady, F. AU - Luthra, S. K. PY - 2005 DA - 2005// TI - The uptake of 3'-deoxy-3'-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels JO - Eur J Nucl Med Mol Imaging VL - 32 UR - https://doi.org/10.1007/s00259-004-1611-0 DO - 10.1007/s00259-004-1611-0 ID - Barthel2005 ER - TY - JOUR AU - O'Neill, K. L. AU - Zhang, F. AU - Li, H. AU - Fuja, D. G. AU - Murray, B. K. PY - 2007 DA - 2007// TI - Thymidine kinase 1—a prognostic and diagnostic indicator in ALL and AML patients JO - Leukemia VL - 21 UR - https://doi.org/10.1038/sj.leu.2404536 DO - 10.1038/sj.leu.2404536 ID - O'Neill2007 ER - TY - JOUR AU - Buck, A. K. AU - Bommer, M. AU - Juweid, M. E. AU - Glatting, G. AU - Stilgenbauer, S. AU - Mottaghy, F. M. PY - 2008 DA - 2008// TI - First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidine JO - J Nucl Med VL - 49 UR - https://doi.org/10.2967/jnumed.108.055335 DO - 10.2967/jnumed.108.055335 ID - Buck2008 ER - TY - JOUR AU - Maeda, T. AU - Kosugi, S. AU - Ujiie, H. AU - Osumi, K. AU - Fukui, T. AU - Yoshida, H. PY - 2003 DA - 2003// TI - Localized relapse in bone marrow in a posttransplantation patient with t(6;9) acute myeloid leukemia JO - Int J Hematol VL - 77 UR - https://doi.org/10.1007/BF02986623 DO - 10.1007/BF02986623 ID - Maeda2003 ER - TY - JOUR AU - Endo, T. AU - Sato, N. AU - Koizumi, K. AU - Nishio, M. AU - Fujimoto, K. AU - Sakai, T. PY - 2004 DA - 2004// TI - Localized relapse in bone marrow of extremities after allogeneic stem cell transplantation for acute lymphoblastic leukemia JO - Am J Hematol VL - 76 UR - https://doi.org/10.1002/ajh.20106 DO - 10.1002/ajh.20106 ID - Endo2004 ER - TY - JOUR AU - Ravandi, F. PY - 2013 DA - 2013// TI - Relapsed acute myeloid leukemia: why is there no standard of care? JO - Best Pract Res Clin Haematol VL - 26 UR - https://doi.org/10.1016/j.beha.2013.10.005 DO - 10.1016/j.beha.2013.10.005 ID - Ravandi2013 ER - TY - STD TI - National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines): non-Hodgkin’s lymphomas (Version 1.2017). http://www.nccn.org/professionals/physiciangls/pdf/b-cell.pdf. Accessed 22 Aug 2017. UR - http://www.nccn.org/professionals/physiciangls/pdf/b-cell.pdf ID - ref31 ER - TY - STD TI - ClinicalTrials.gov. US Bethesda, Maryland. 2000: Identifier NCT02392429. FLT PET/CT in measuring response in patients with previously untreated acute myeloid leukemia. 18 March 2015. https://clinicaltrials.gov/ct2/show/NCT02392429. Accessed 4 Sep 2017. UR - https://clinicaltrials.gov/ct2/show/NCT02392429 ID - ref32 ER -